A promoter polymorphism (-839 C>T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 144, Issue 2, 2007, Pages 215-219

  Genro, Júlia P ^a   Zeni, Cristian ^a   Polanczyk, Guilherme V ^a   Roman, Tatiana ^b   Rohde, Luis A ^a   Hutz, Mara H ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Faculdade Fed de Ciencias Medicas   (Brazil)

Author keywords

ADHD; DAT1; Dopamine transporter; SLC6A3

Indexed keywords

3' UNTRANSLATED REGION; ADOLESCENT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; BRAZIL; CHILD; DAT1 GENE; DOPAMINERGIC TRANSMISSION; FAMILY ASSESSMENT; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; VARIABLE NUMBER OF TANDEM REPEAT; VERTICAL TRANSMISSION; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

CYTOSINE; DOPAMINE TRANSPORTER; SLC6A3 PROTEIN, HUMAN; THYMINE; UNCLASSIFIED DRUG;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAZIL; CHILD; CYTOSINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MINISATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); THYMINE;

EID: 34047249904     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30428     Document Type: Article

References (58)

1. Arcos-Burgos M, Castellanos FX, Pineda D, Lopera F, Palacio JD, Palacio LG, Rapoport JL, Berg K, Bailey-Wilson JE, Muenke M. 2004. Attention-deficit/ hyperactivity disorder in a population isolate: Linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am J Hum Genet 75:998-1014.
2. Bakker SC, van der Meulen EM, Buitelaar JK, Sandkuijl LA, Pauls DL, Monsuur AJ, van't Slot R, Minderaa RB, Gunning WB, Pearson PL, Sinke RJ. 2003. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: Suggestive evidence for linkage on chromosomes 7p and 15q. Am J Hum Genet 72:1251-1260.
3. Bannon MJ. 2005. The dopamine transporter: Role in neurotoxicity and human disease. Toxicol Appl Pharmacol 204:355-360.
4. Bannon MJ, Pruetz B, Barfield E, Schmidt CJ. 2004. Transcription factors specifying dopamine phenotype are decreased in cocaine users. Neuroreport 15:401-404.
5. Barr CL, Xu C, Kroft J, Feng Y, Wigg K, Zai G, Tannock R, Schachar R, Malone M, Roberts W, Nothen MM, Grunhage F, Vandenbergh DJ, Uhl G, Sunohara G, King N, Kennedy JL. 2001. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Biol Psychiatry 49:333-339.
6. Chen CK, Chen SL, Mill J, Huang YS, Lin SK, Curran S, Purcell S, Sham P, Asherson P. 2003. The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample. Mol Psychiatry 8:393-396.
7. Cheon KA, Ryu YH, Kim YK, Namkoong K, Kim CH, Lee JD. 2003. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. Eur J Nucl Med Mol Imaging 30:306-311.
8. Clayton D. 1999. A generalization of the transmission/disequilibrium test for uncertain haplotype transmission. Am J Hum Genet 65:1170-1177.
9. Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL. 1995. Association of attention deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993-998.
10. Daly G, Hawi Z, Fitzgerald M, Gill M. 1999. Mapping susceptibility loci in attention-deficit/hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 4:192-196.
11. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ. 1999. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354:2132-2133.
12. Dresel S, Krause J, Krause KH, LaFougere C, Brinkbaumer K, Kung HF, Hahn K, Tatsch K. 2000. Attention deficit hyperactivity disorder: Binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med 27:1518-1524.
13. Faraone SV, Sergeant J, Gillberg C, Biederman J. 2003. The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry 2:104-113.
14. Faraone SV, Perils RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. 2005. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313-1323.
15. Feng Y, Wigg KG, Makkar R, Ickowicz A, Pathare T, Tannock R, Roberts W, Malone M, Kennedy JL, Schachar R, Barr CL. 2005. Sequence variation in the 3′-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD). Am J Med Genet Part B Neuropsychiatr Genet 139:1-6.
16. Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL, Newbury DF, Crawford LR, Palmer CG, Woodward JA, Del'Homme M, Cantwell DP, Nelson SF, Monaco AP, Smalley SL. 2002. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet 70:1183-1196.
17. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. 2001. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 1:152-156.
18. Galili-Weisstub E, Levy S, Frisch A, Gross-Tsur V, Michaelovsky E, Kosov A, Meltzer A, Goltser T, Serretti A, Cusin C, Darvasi A, Inbar E, Weizman A, Segman RH. 2005. Dopamine transporter haplotype and attention-deficit hyperactivity disorder. Mol Psychiatry 10:617-618.
19. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. 1997. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 2:311-313.
20. Greenwood TA, Kelsoe JR. 2003. Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics 82:511-520.
21. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, Kelsoe JR. 2001. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet 105:145-151.
22. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, Shaw SH, Kelsoe JR. 2002. Segmental linkage disequilibrium within the dopamine transporter gene. Mol Psychiatry 7:165-173.
23. Greenwood TA, Schork NJ, Eskin E, Kelsoe JR. 2006. Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples. Mol Psychiatry 11:125-133.
24. Hawi Z, Lowe N, Kirley A, Gruenhage F, Nothen M, Greenwood T, Kelsoe J, Fitzgerald M, Gill M. 2003. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry 8:299-308.
25. Hebebrand J, Dempfle A, Saar K, Thiele H, Herpertz-Dahlmann B, Linder M, Kiefl H, Remschmidt H, Hemminger U, Warnke A, Knolker U, Heiser P, Friedel S, Hinney A, Schafer H, Nurnberg P, Konrad K. 2006. A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Mol Psychiatry 11:196-205.
26. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR. 2000. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22:133-139.
27. Holmes J, Payton A, Barrett JH, Hever T, Fitzpatrick H, Trumper AL, Harrington R, McGuffin P, Owen M, Ollier W, Worthington J, Thapar A. 2000. A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol Psychiatry 5:523-530.
28. Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB, Gelernter J. 2000. Prediction of dopamine transporter binding availability by genotype: A preliminary report. Am J Psychiatry 157:1700-1703.
29. Kelada SN, Costa-Mallen P, Checkoway H, Carlson CS, Weller TS, Swanson PD, Franklin GM, Longstreth WT Jr, Afsharinejad Z, Costa LG. 2005. Dopamine transporter (SLC6A3) 5′ region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease. Pharmacogenet Genomics 15:659-668.
30. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K. 2000. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 285:107-110.
31. Lahiri DK, Nurnberger JI. 1991. Rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444.
32. Laird N, Horvath S, Xu X. 2000. Implementing a unified approach to family based tests of association. Genet Epidemiol 19:S36-S42.
33. Langley K, Turic D, Peirce TR, Mills S, Van Den Bree MB, Owen MJ, O'donovan MC, Thapar A. 2005. No support for association between the dopamine transporter (DAT1) gene and ADHD. Am J Med Genet Part B 139B:7-10.
34. Lewontin RC. 1988. On measures of gametic disequilibrium. Genetics 120: 849-852.
35. Lynch DR, Mozley PD, Sokol S, Maas NM, Balcer LJ, Siderowf AD. 2003. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease. Mov Disord 18:804-812.
36. Madras BK, Miller GM, Fischman AJ. 2005. The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1397-1409.
37. Martinez D, Gelernter J, Abi-Dargham A, van Dyck CH, Kegeles L, Innis RB, Laruelle M. 2001. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 24:553-560.
38. Mazei-Robison MS, Couch RS, Shelton RC, Stein MA, Blakely RD. 2005. Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder. Neuropharmacology 49:724-736.
39. Michelhaugh SK, Fiskerstrand C, Lovejoy E, Bannon MJ, Quinn JP. 2001. The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem 79:1033-1038.
40. Mill J, Asherson P, Browes C, D'Souza U, Craig I. 2002. Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114:975-979.
41. Miller GM, Madras BK. 2002. Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 7:44-55.
42. Ogdie MN, Bakker SC, Fisher SE, Francks C, Yang MH, Cantor RM, Loo SK, van der Meulen E, Pearson P, Buitelaar J, Monaco A, Nelson SF, Sinke RJ, Smalley SL. 2006. Pooled genome-wide linkage data on 424 ADHD ASPs suggests genetic heterogeneity and a common risk locus at 5p13. Mol Psychiatry 11:5-8.
43. Palmer CG, Bailey JN, Ramsey C, Cantwell D, Sinsheimer JS, Del'Homme M, McGough J, Woodward JA, Asarnow R, Asarnow J, Nelson S, Smalley SL. 1999. No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample. Psychiatr Genet 9:157-160.
44. Rohde LA. 2002. ADHD in a developing country: Are DSM-IV criteria suitable for culturally different populations? J Am Acad Child Adolesc Psychiatry 41:1131-1133.
45. Roman T, Schmitz M, Polanczyk G, Eizirik M, Rohde LA, Hutz MH. 2001. Attention-deficit/hyperactivity disorder: A study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet (Neuropsychiatr Genet) 105:471-478.
46. Roman T, Rohde LA, Hutz MH. 2004. Polymorphisms of the dopamine transporter gene: Influence on response to methylphenidade in attention deficit-hyperactivity disorder. Am J Pharmacogenomics 4: 83-92.
47. Rowe DC, Stever C, Chase D, Sherman S, Abramowitz A, Waldman ID. 2001. Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms. Mol Psychiatry 6:429-433.
48. Rubie C, Schmidt F, Knapp M, Sprandel J, Wiegand C, Meyer J, Jungkunz G, Riederer P, Stober G. 2001. The human dopamine transporter gene: The 5′-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample. Neurosci Lett 297:125-128.
49. Schneider S, Roessli D, Excoffier L. 2000. Arlequin (ver. 2000). A software for population genetics data analysis. Geneva: Universidade de Geneva.
50. Sergeant J. 2005. Are we ready for endophenotypes in attention deficit hyperactivity disorder? Rev Bras Psiquiatr 27:262-263.
51. Sklar P. 2005. Principles of haplotype mapping and potential applications to attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1357-1366.
52. Smith KM, Daly M, Fischer M, Yiannoutsos CT, Bauer L, Barkley R, Navia BA. 2003. Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: Genetic analysis of the Milwaukee longitudinal study. Am J Med Genet Part B 119B:77-85.
53. Swanson JM, Flodman P, Kennedy J, Spence MA, Moyzis R, Schuck S, Murias M, Moriarity J, Barr C, Smith M, Posner M. 2000. Dopamine genes and ADHD. Neurosci Biobehav Rev 24:21-25.
54. Todd RD, Jong YJ, Lobos EA, Reich W, Heath AC, Neuman RJ. 2001. No association of the dopamine transporter gene 3′ VNTR polymorphism with ADHD subtypes in a population sample of twins. Am J Med Genet 105:745-748.
55. Todd RD, Huang H, Smalley SL, Nelson SF, Willcutt EG, Pennington BF, Smith SD, Faraone SV, Neuman RJ. 2005. Collaborative analysis of DRD4 and DAT genotypes in population-defined ADHD subtypes. J Child Psychol Psychiatry 46:1067-1073.
56. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR. 1992. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14:1104-1106.
57. Waldman ID, Gizer IR. 2006. The genetics of attention deficit hyperactivity disorder. Clin Psychol Rev 26:396-432.
58. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL, Cleveland HH, Sanders ML, Gard JMC, Stever C. 1998. Association and linkage of the dopamine transporter gene (DAT1) and attention-deficit/hyperactivity disorder in children. Am J Hum Genet 63:1767-1776.